Publications
4 shownNivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...
The Immune Landscape of Cancer
We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we identi...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 15,290
- Institution
- Dana-Farber Cancer Institute
External Links
Identifiers
- ORCID
- 0000-0002-9201-3217
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.